NCT00608205 · OUTCOME

Nausea Level

Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer · Source last updated 2020-08-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: units on a scale
Interval / dispersion: Standard Deviation
Time frame: 24 months from start of treatment

What was measured

Quality of life questionnaire asking "I have nausea".

Analysis population: Patients still alive from Cleveland Clinic only. University Hospital patients were not included in this analysis.

Groups in this outcome

Radiation With Concurrent Cisplatin

Patients undergo full-dose radiotherapy once or twice daily 5 days a week for up to 7 weeks and receive cisplatin IV over 1 hour on days 1, 22, and 43 of radiotherapy.

Radiation With Concurrent 5-FU and Cisplatin

Patients undergo radiotherapy as in arm I and receive fluorouracil IV and cisplatin IV continuously on days 1-4 and 22-25 of radiotherapy.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Radiation With Concurrent Cisplatin	21
Radiation With Concurrent 5-FU and Cisplatin	16

Reported measurements

Source class 1

Values in units on a scale · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Radiation With Concurrent Cisplatin	0.10	0.3	Not reported	Not reported	Not reported
Radiation With Concurrent 5-FU and Cisplatin	0	0	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
0.3
value
0.10
group Id
OG001
spread
0
value
0

denoms

counts
group Id
OG000
value
21
group Id
OG001
value
16
units
Participants

description

Quality of life questionnaire asking "I have nausea".

dispersion Type

Standard Deviation

groups

description
Patients undergo full-dose radiotherapy once or twice daily 5 days a week for up to 7 weeks and receive cisplatin IV over 1 hour on days 1, 22, and 43 of radiotherapy.
id
OG000
title
Radiation With Concurrent Cisplatin
description
Patients undergo radiotherapy as in arm I and receive fluorouracil IV and cisplatin IV continuously on days 1-4 and 22-25 of radiotherapy.
id
OG001
title
Radiation With Concurrent 5-FU and Cisplatin

param Type

MEAN

population Description

Patients still alive from Cleveland Clinic only. University Hospital patients were not included in this analysis.

reporting Status

POSTED

time Frame

24 months from start of treatment

title

Nausea Level

type

SECONDARY

unit Of Measure

units on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice